The World Health Organisation (WHO) prequalified a new dengue vaccine TAK-003 on May 10. TAK-003, developed by Takeda, is ...

A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue vaccine to be prequalified by WHO. Developed by Takeda, it ...

The prequalification of TAK-003 is an important step in the expansion of global access to dengue vaccines, as it is now eligible for procurement by UN agencies including UNICEF. Photo: AFP A new ...

TAK-003 is the second dengue vaccine to be prequalified by WHO Geneva: The World Health Organization (WHO) said on Wednesday that it had prequalified Takeda Pharmaceuticals' dengue vaccine.

The World Health Organization (WHO) has officially prequalified a new vaccine designed to combat the mosquito-borne viral disease; dengue fever. The WHO announced a news release on Wednesday, May 15, ...

, opens new tab dengue vaccine, giving international procurement agencies another option against the disease that affects millions of people each year. The approval, called a prequalification ...

The World Health Organization (WHO) has prequalified a new dengue vaccine known as TAK-003. Developed by Takeda, this live-attenuated vaccine, which incorporates weakened forms of the four dengue ...

Dengue is a vector-borne disease transmitted by the bite of an infected mosquito. (Image Credits: Pixabay) The World Health Organization (WHO) on Wednesday announced that it has prequalified new ...

The World Health Organisation (WHO) marked a significant milestone in the global fight against dengue fever with the prequalification of a new vaccine, TAK-003 on May 10, 2024. Developed by Takeda ...

The WHO has prequalified a second dengue vaccine called TAK-003 The TAK-003 vaccine has been made by the Japanese drug maker Takeda Pharmaceuticals TAK-003 can be administered to children aged 6 to 16 ...